Home › High Blood Pressure › Louisiana › Baton Rouge
High Blood Pressure clinical trials in Baton Rouge, LA
3 studies for High Blood Pressure are looking for participants at sites in and around Baton Rouge (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
RecruitingPhase 3
- Southern Clinical Research - Zachary, Zachary · 14 mi away
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
RecruitingPhase 3
- Pennington Biomedical Research Center, Baton Rouge
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
RecruitingPhase 3
- Clinical Trial Site, Zachary · 14 mi away
About High Blood Pressure
High blood pressure (hypertension) develops when blood flows through arteries at higher than normal pressures. It increases the risk for heart disease and stroke.
More about High Blood Pressure on MedlinePlus
High Blood Pressure trials in other cities
- Chicago, IL21 studies
- Boston, MA21 studies
- Dallas, TX16 studies
- Nashville, TN13 studies
- Houston, TX11 studies
- Birmingham, AL11 studies
- Durham, NC10 studies
- Atlanta, GA10 studies
- Tucson, AZ10 studies
- New York City, NY9 studies
- Miami, FL9 studies
- Baltimore, MD9 studies
Other studies in Baton Rouge
- Obesity15 studies
- Overweight10 studies
- Non-Small Cell Lung Cancer10 studies
- Metastatic Cancer9 studies
- Acute Myeloid Leukemia8 studies
- Lung Cancer8 studies
- Colorectal Cancer8 studies
- Breast Cancer7 studies
- Bladder Cancer6 studies
- Chronic Lymphocytic Leukemia5 studies
- Prostate Cancer5 studies
- COPD5 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.